ATLASProtara Therapeutics (TARA) earnings date: Nov 9, 2026
Protara Therapeutics (TARA) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026. Analysts expect EPS of -$0.37.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on TARA
| Last price | $2.39 (-3.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.6% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Protara Therapeutics stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Protara Therapeutics reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Protara Therapeutics. You can switch it off at any time.
Alert me before TARA reportsFree to start. Creating an account takes under a minute.
Notify me when Protara Therapeutics reports
Track TARA free Add Protara Therapeutics to a free ATLAS watchlist and see its next report date in one place.
TARA earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.37 |
| Last report | Aug 11, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +10.9% |
| Average move around a report | ±3.4% (last 5) |
| Sector | Healthcare · Biotechnology |
Protara Therapeutics earnings history: last 5 reports
Protara Therapeutics last reported on Aug 11, 2026: EPS of -$0.36 against an estimate of -$0.31 (-16.1% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 11, 2026 | -$0.31 | -$0.36 | -16.1% | Miss | -5.4% |
| Jul 30, 2026 | $2.51 | $2.62 | +4.4% | Beat | +2.9% |
| Jun 11, 2026 | -$0.33 | -$0.09 | +72.7% | Beat | +3.2% |
| May 13, 2026 | -$0.37 | -$0.31 | +16.2% | Beat | +2.9% |
| Mar 10, 2026 | -$0.31 | -$0.38 | -22.6% | Miss | -2.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for TARA
See the fair value, the probability range and the earnings history of Protara Therapeutics on its ATLAS page.
Protara Therapeutics (TARA) stock analysisPlans from €3.99 a month.
Protara Therapeutics earnings: frequently asked questions
When does Protara Therapeutics (TARA) report earnings?
Protara Therapeutics is scheduled to report on Monday, November 9, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for TARA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.37 per share (USD). Estimates can change before the report.
How often does TARA beat earnings estimates?
Of its last 5 reports with a recorded result, Protara Therapeutics beat the EPS estimate 3 times; the average surprise was +10.9%. Past results do not predict the next one.
How much does TARA move around earnings?
Over its last 5 reports the stock moved an average of 3.4% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Protara Therapeutics beat earnings estimates last quarter?
Protara Therapeutics last reported on Aug 11, 2026: EPS of -$0.36 against an estimate of -$0.31 (-16.1% surprise), a miss.
How much does TARA usually move in a day?
On a normal trading day the ATLAS model puts TARA’s one-day range at about ±3.6%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer